Hepatitis prophylaxis.
D000208:Acute Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006506:Hepatitis A / Q000517:prevention & control*; D006509:Hepatitis B / Q000517:prevention & control* / Q000628:therapy; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D011897:Random Allocation; D014765:Viral Vaccines / Q000627:therapeutic use*; D005719:gamma-Globulins / Q000627:therapeutic use
D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D014765:Viral Vaccines; D005719:gamma-Globulins